These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10660314)

  • 1. A case of acquired iris depigmentation as a possible complication of levobunolol eye drops.
    Doyle E; Liu C
    Br J Ophthalmol; 1999 Dec; 83(12):1405-6. PubMed ID: 10660314
    [No Abstract]   [Full Text] [Related]  

  • 2. Drops and falls.
    Spratt A; Ogunbowale L; Khawaja A; Franks W
    Age Ageing; 2006 Nov; 35(6):646. PubMed ID: 17047012
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic contact dermatitis from levobunolol eyedrops.
    di Lernia V; Albertini G; Bisighini G
    Contact Dermatitis; 1995 Jul; 33(1):57. PubMed ID: 7493471
    [No Abstract]   [Full Text] [Related]  

  • 4. Allergic contact dermatitis due to levobunolol in an ophthalmic preparation.
    Hashimoto Y; Aragane Y; Kawada A
    J Dermatol; 2006 Jul; 33(7):507-9. PubMed ID: 16848829
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute iris depigmentation following systemic moxifloxacin.
    Nascimento HM; Sousa JM; Campos MS; Belfort R
    Clinics (Sao Paulo); 2013 Jul; 68(7):899-900. PubMed ID: 23917650
    [No Abstract]   [Full Text] [Related]  

  • 6. Contact dermatitis to levobunolol eyedrops superimposed on IgE-mediated rhinoconjunctivitis.
    Blumetti B; Brodell RT; Helms SE; Brodell LP; Bredle DL
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):817-8. PubMed ID: 17201244
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of patch testing with levobunolol eyedrops to detect contact allergy.
    Statham BN
    Contact Dermatitis; 2000 Dec; 43(6):365-6. PubMed ID: 11140394
    [No Abstract]   [Full Text] [Related]  

  • 8. Contact dermatitis from levobunolol and befunolol.
    Zucchelli V; Silvani S; Vezzani C; Lorenzi S; Tosti A
    Contact Dermatitis; 1995 Jul; 33(1):66-7. PubMed ID: 7493479
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic contact dermatitis due to levobunolol with cross-sensitivity to befunolol.
    Nino M; Balato A; Ayala F; Balato N
    Contact Dermatitis; 2007 Jan; 56(1):53-4. PubMed ID: 17177718
    [No Abstract]   [Full Text] [Related]  

  • 10. Iris morphology.
    Teus MA; Arranz-Marquez E
    Ophthalmology; 2008 Feb; 115(2):418-9; author reply 419-20. PubMed ID: 18243921
    [No Abstract]   [Full Text] [Related]  

  • 11. Bradyarrhythmias secondary to topical levobunolol hydrochloride solution.
    Lin L; Wang Y; Chen Y; Liu M
    Clin Interv Aging; 2014; 9():1741-5. PubMed ID: 25342892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased iris pigment in a child due to latanoprost.
    Brown SM
    Arch Ophthalmol; 1998 Dec; 116(12):1683-4. PubMed ID: 9869807
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of once-daily levobunolol on intraocular pressure in normal-tension glaucoma.
    Inoue K; Ezure T; Wakakura M; Inoue J; Tomita G
    Jpn J Ophthalmol; 2005; 49(1):58-9. PubMed ID: 15692777
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary: Bilateral acute depigmentation of iris.
    Murugan SB
    Indian J Ophthalmol; 2019 Jan; 67(1):134. PubMed ID: 30574916
    [No Abstract]   [Full Text] [Related]  

  • 15. Iris heterochromia and unilateral eyelash hypertrichosis.
    Rao RC; Ballard TN; Chen TC
    JAMA; 2015 May; 313(19):1967-8. PubMed ID: 25988467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral acute depigmentation of iris.
    Yangzes S; Singh SR; Ram J
    Indian J Ophthalmol; 2019 Jan; 67(1):133. PubMed ID: 30574915
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological pseudo-Fuchs].
    Sevillano Torrado C; Lugo Adán E; Viso Outeiriño E
    Arch Soc Esp Oftalmol; 2013 Jul; 88(7):283-5. PubMed ID: 23768478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypersensitivity to levobunolol].
    Schultheiss E
    Derm Beruf Umwelt; 1989; 37(5):185-6. PubMed ID: 2530078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma.
    Halper LK; Johnson-Pratt L; Dobbins T; Hartenbaum D
    J Ocul Pharmacol Ther; 2002 Apr; 18(2):105-13. PubMed ID: 12002664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betaxolol and levobunolol: new beta-blocking antiglaucoma agents.
    Tierney DW
    J Am Optom Assoc; 1987 Sep; 58(9):722-7. PubMed ID: 2895783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.